Home Search
COVID-19 - search results
If you're not happy with the results, please do another search
Climate change, environmental justice and COVID-19
Here, Professor Pamela Lein at University of California, Davis, explains the 'perfect storm' unfolding in the intersection of climate change, environmental justice and COVID-19.
COVID-19 and its impact on society
European Public Health Association Executive Director, Dineke Zeegers Paget, updates us about COVID-19 and its impact on society, public health, healthcare and equitable access to vaccines.
The Brain: an unexpeted target of COVID-19
Here, Professor Pamela Lein at University of California, Davis, discusses the relatively unexplored issue of the human brain as a target of COVID-19.
COVID-19 can trigger repeating blood clots in arm
A team at Rutgers Robert Wood Johnson Medical School have found evidence of rare, repeating blood clots in the arms of COVID-19 patients.
What lasting legacies of COVID-19 will local government take forward?
Lorraine Smith, Divisional Managing Director at Civica, discusses how the pandemic has not only re-shaped local government when it comes to new ways of working but also in transforming citizen engagement.
Options for struggling businesses in the aftermath of COVID-19
John Bell, director and founder of Clarke Bell, ponders the impact of COVID-19 on the economy and what options struggling businesses could be facing in the coming months and years ahead.
COVID-19 vaccine does not damage placentas
Researchers from Northwestern Medicine have studied the placentas from patients who received the COVID-19 vaccine during pregnancy and found no evidence of damage.
HIV patients are more likely to die from COVID-19
In a new study, researchers have found that individuals living with HIV and AIDS have an increased risk of death from COVID-19 infection.
Mild COVID-19 infection is unlikely to cause permanent heart damage
According to a new study by researchers at UCL, mild COVID-19 infection is highly unlikely to cause lasting heart damage.
Researchers given £5m to understand COVID-19 severity in India and the UK
Four research partnerships have been awarded £5 million to provide a deeper understanding of COVID-19 severity in India and the UK.
Dementia patients should be given priority for the COVID-19 vaccine
Alzheimer Europe has issued a call for people with dementia and their carers to be given priority for the COVID-19 vaccine.
Only 41% of people are willing to sign up for COVID-19 vaccine trials
New research from the University of Birmingham shows that only 41% of people would be willing to sign up for COVID-19 vaccine trials.
One third of hospitalised COVID-19 patients show lung changes one year on
A new study has found that one-third of COVID-19 patients discharged from hospital still present lung changes one year on.
COVID-19 variant vaccines will be fast-tracked through cutting-edge testing centre
Health Secretary Matt Hancock has announced that vaccines tailored to tackle COVID-19 variants will be fast-tracked through new state-of-the-art labs.
Changes in hospital mortality during the COVID-19 pandemic
Researchers have published the most comprehensive study of COVID-19 hospital mortality rates in the United States.
Social media users more likely to believe COVID-19 conspiracy theories
A study by Annenberg Public Policy Center (APPC) researchers has found that users of conservative and social media are more likely to believe COVID-19 conspiracy theories.
Single COVID-19 vaccine protects against variants in those with previous infection
A new study has found that a single dose of the COVID-19 vaccine boosts protection against SARS-CoV-2 variants, but only in those with previous infection.
NHS offers COVID-19 vaccine to all people 40 and over
The NHS is now inviting everyone aged 40 and over to book in for a COVID-19 vaccine.
Single COVID-19 vaccine dose reduces household transmission by 49%
New Public Health England (PHE) study finds that one dose of the COVID-19 vaccine reduces household transmission by up to 49%.
Combination of remdesivir and hep C drugs effective against COVID-19
A combination of remdesivir and drugs for hepatitis C virus (HCV) have presented strong effectiveness against COVID-19 in a new study.